2025091030 — GYC/GGpeps Tirzepatide
Vendor COAGYC/GGpeps | Tirzepatide, last activity 3 weeks ago
8 related batch concerns
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 30 mg. Janoshik weighed 36.6 mg — 22% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
16 units
on a U-100 insulin syringe, for 3 mg
Going by the label you would draw 20 units — which from this vial is actually 3.66 mg, not 3 mg.
- The vial holds dry powder: 36.6 mg of Tirzepatide, as weighed.
- Water spreads that powder evenly through the liquid: 36.6 mg ÷ 2 ml = 18.3 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 183 mcg.
- Your dose divided by that: 3 mg ÷ 183 mcg = 16 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
Endotoxin levels have exceeded the 10 EU/vial working limit in two independent Janoshik tests (17.116 and 47.923…
same lot series
2 community mentions, no summary yet
Retatrutide, same vendor
This batch has endotoxin at 57.403 EU/vial per the vendor's Janoshik certificate—over five times the 10 EU/vial working…
SPB
SPB rarely publishes certificates, and this batch has two quality concerns reported against it
same lot series
1 community mention, no summary yet
Community Intelligence
- 1 concern report involving 2026061030
- 2 concern reports involving 2026041210
- 1 concern report involving 2026091215
- 1 concern report involving 2026061215
- 1 concern report involving 2026031310
- 2 concern reports involving 2026071210
- 1 concern report involving 2026071220
- 2 concern reports involving SN26XY-1-02
Reported against other GYC/GGpeps Tirzepatide batches, not this one.
Also known as: 202509-1030
Activity
No community activity tracked yet.
Vendor
GYC/GGpeps